Literature DB >> 19490962

Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.

Mitali Sarkar-Tyson1, Sophie J Smither, S V Harding, Timothy P Atkins, Richard W Titball.   

Abstract

Burkholderia pseudomallei and Burkholderia mallei are gram-negative bacilli that are the causative agents of melioidosis and glanders, respectively. Both humans and animals are susceptible to both diseases. There is currently no vaccine available for the prevention of disease. We report the protective efficacy of heat-inactivated Burkholderia thailandensis, B. mallei or B. pseudomallei cells as vaccines against murine melioidosis and glanders. Immunisation with heat-inactivated B. pseudomallei cells provided the highest levels of protection against either melioidosis or glanders. These studies indicate the longer term potential for heat-inactivated bacteria to be developed as vaccines against melioidosis and glanders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490962     DOI: 10.1016/j.vaccine.2009.05.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Efficacy of postexposure therapy against glanders in mice.

Authors:  David M Waag
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Authors:  Laura Conejero; Natasha Patel; Melanie de Reynal; Sara Oberdorf; Joanne Prior; Philip L Felgner; Richard W Titball; Francisco J Salguero; Gregory J Bancroft
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

4.  A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Authors:  Wildaliz Nieves; Hailey Petersen; Barbara M Judy; Carla A Blumentritt; Kasi Russell-Lodrigue; Chad J Roy; Alfredo G Torres; Lisa A Morici
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

5.  Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Authors:  Andrew E Scott; Thomas R Laws; Riccardo V D'Elia; Margaret G M Stokes; Tannistha Nandi; E Diane Williamson; Patrick Tan; Joann L Prior; Timothy P Atkins
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

6.  Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.

Authors:  Chui-Yoke Chin; Swee-Chen Tan; Sheila Nathan
Journal:  Front Cell Infect Microbiol       Date:  2012-06-15       Impact factor: 5.293

7.  Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.

Authors:  Mary N Burtnick; Christian Heiss; Rosemary A Roberts; Herbert P Schweizer; Parastoo Azadi; Paul J Brett
Journal:  Front Cell Infect Microbiol       Date:  2012-08-15       Impact factor: 5.293

Review 8.  Burkholderia vaccines: are we moving forward?

Authors:  Leang-Chung Choh; Guang-Han Ong; Kumutha M Vellasamy; Kaveena Kalaiselvam; Wen-Tyng Kang; Anis R Al-Maleki; Vanitha Mariappan; Jamuna Vadivelu
Journal:  Front Cell Infect Microbiol       Date:  2013-02-05       Impact factor: 5.293

Review 9.  Development of Burkholderia mallei and pseudomallei vaccines.

Authors:  Ediane B Silva; Steven W Dow
Journal:  Front Cell Infect Microbiol       Date:  2013-03-11       Impact factor: 5.293

10.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.